{"id":"https://openalex.org/W2160994126","doi":"https://doi.org/10.1158/1078-0432.ccr-06-3091","title":"Functional Up-regulation of Human Leukocyte Antigen Class I Antigens Expression by 5-aza-2\u2032-deoxycytidine in Cutaneous Melanoma: Immunotherapeutic Implications","display_name":"Functional Up-regulation of Human Leukocyte Antigen Class I Antigens Expression by 5-aza-2\u2032-deoxycytidine in Cutaneous Melanoma: Immunotherapeutic Implications","alternate_titles":[],"publication_year":2007,"publication_date":"2007-06-01","ids":{"openalex":"https://openalex.org/W2160994126","doi":"https://doi.org/10.1158/1078-0432.ccr-06-3091","mag":"2160994126","pmid":"https://pubmed.ncbi.nlm.nih.gov/17545540"},"language":"en","primary_location":{"id":"doi:10.1158/1078-0432.ccr-06-3091","doi":"https://doi.org/10.1158/1078-0432.ccr-06-3091","is_oa":false,"landing_page_url":"https://doi.org/10.1158/1078-0432.ccr-06-3091","pdf_url":null,"source":{"id":"https://openalex.org/S183149254","display_name":"Clinical Cancer Research","issn_l":"1078-0432","issn":["1078-0432","1557-3265"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Clinical Cancer Research","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W2160994126"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"green","oa_url":"https://aacrjournals.org/clincancerres/article/13/11/3333/193340/Functional-Up-regulation-of-Human-Leukocyte","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5110110268","display_name":"Ester Fonsatti","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I102064193","display_name":"University of Siena","ror":"https://ror.org/01tevnk56","country_code":"IT","type":"education","lineage":["https://openalex.org/I102064193"]}],"countries":["IT"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Ester Fonsatti","raw_affiliation_strings":["1Division of Medical Oncology and Immunotherapy, Department of Oncology, University Hospital of Siena, Istituto Toscano Tumori, Siena, Italy;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Division of Medical Oncology and Immunotherapy, Department of Oncology, University Hospital of Siena, Istituto Toscano Tumori, Siena, Italy;","institution_ids":["https://openalex.org/I102064193"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5019420264","display_name":"Hugues J. M. Nicolay","orcid":"https://orcid.org/0000-0001-9264-7001","observed_orcids":["https://orcid.org/0000-0001-9264-7001"]},"institutions":[{"id":"https://openalex.org/I102064193","display_name":"University of Siena","ror":"https://ror.org/01tevnk56","country_code":"IT","type":"education","lineage":["https://openalex.org/I102064193"]},{"id":"https://openalex.org/I4210128630","display_name":"Centro di Riferimento Oncologico","ror":"https://ror.org/03ks1vk59","country_code":"IT","type":"healthcare","lineage":["https://openalex.org/I4210128630","https://openalex.org/I4210153126"]}],"countries":["IT"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Hugues J.M. Nicolay","raw_affiliation_strings":["1Division of Medical Oncology and Immunotherapy, Department of Oncology, University Hospital of Siena, Istituto Toscano Tumori, Siena, Italy;","2Cancer Bioimmunotherapy Unit, Department of Medical Oncology, Centro di Riferimento Oncologico, Istituto di Ricovero e Cura a Carattere Scientifico, Aviano, Italy; and","1Division of Medical Oncology and Immunotherapy, Department of Oncology, University Hospital of Siena, Istituto Toscano Tumori, Siena, Italy;; 2Cancer Bioimmunotherapy Unit, Department of Medical Oncology, Centro di Riferimento Oncologico, Istituto di Ricovero e Cura a Carattere Scientifico, Aviano, Italy; and"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Division of Medical Oncology and Immunotherapy, Department of Oncology, University Hospital of Siena, Istituto Toscano Tumori, Siena, Italy;","institution_ids":["https://openalex.org/I102064193"]},{"raw_affiliation_string":"2Cancer Bioimmunotherapy Unit, Department of Medical Oncology, Centro di Riferimento Oncologico, Istituto di Ricovero e Cura a Carattere Scientifico, Aviano, Italy; and","institution_ids":["https://openalex.org/I4210128630"]},{"raw_affiliation_string":"1Division of Medical Oncology and Immunotherapy, Department of Oncology, University Hospital of Siena, Istituto Toscano Tumori, Siena, Italy;; 2Cancer Bioimmunotherapy Unit, Department of Medical Oncology, Centro di Riferimento Oncologico, Istituto di Ricovero e Cura a Carattere Scientifico, Aviano, Italy; and","institution_ids":["https://openalex.org/I102064193","https://openalex.org/I4210128630"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5047924306","display_name":"Luca Sigalotti","orcid":"https://orcid.org/0000-0002-1436-2358","observed_orcids":["https://orcid.org/0000-0002-1436-2358"]},"institutions":[{"id":"https://openalex.org/I4210128630","display_name":"Centro di Riferimento Oncologico","ror":"https://ror.org/03ks1vk59","country_code":"IT","type":"healthcare","lineage":["https://openalex.org/I4210128630","https://openalex.org/I4210153126"]}],"countries":["IT"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Luca Sigalotti","raw_affiliation_strings":["2Cancer Bioimmunotherapy Unit, Department of Medical Oncology, Centro di Riferimento Oncologico, Istituto di Ricovero e Cura a Carattere Scientifico, Aviano, Italy; and"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"2Cancer Bioimmunotherapy Unit, Department of Medical Oncology, Centro di Riferimento Oncologico, Istituto di Ricovero e Cura a Carattere Scientifico, Aviano, Italy; and","institution_ids":["https://openalex.org/I4210128630"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5008516429","display_name":"Luana Calabr\u00f2","orcid":"https://orcid.org/0000-0002-3044-0889","observed_orcids":["https://orcid.org/0000-0002-3044-0889"]},"institutions":[{"id":"https://openalex.org/I102064193","display_name":"University of Siena","ror":"https://ror.org/01tevnk56","country_code":"IT","type":"education","lineage":["https://openalex.org/I102064193"]}],"countries":["IT"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Luana Calabro\u0300","raw_affiliation_strings":["1Division of Medical Oncology and Immunotherapy, Department of Oncology, University Hospital of Siena, Istituto Toscano Tumori, Siena, Italy;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Division of Medical Oncology and Immunotherapy, Department of Oncology, University Hospital of Siena, Istituto Toscano Tumori, Siena, Italy;","institution_ids":["https://openalex.org/I102064193"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5042171036","display_name":"Laura Pezzani","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210128630","display_name":"Centro di Riferimento Oncologico","ror":"https://ror.org/03ks1vk59","country_code":"IT","type":"healthcare","lineage":["https://openalex.org/I4210128630","https://openalex.org/I4210153126"]}],"countries":["IT"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Laura Pezzani","raw_affiliation_strings":["2Cancer Bioimmunotherapy Unit, Department of Medical Oncology, Centro di Riferimento Oncologico, Istituto di Ricovero e Cura a Carattere Scientifico, Aviano, Italy; and"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"2Cancer Bioimmunotherapy Unit, Department of Medical Oncology, Centro di Riferimento Oncologico, Istituto di Ricovero e Cura a Carattere Scientifico, Aviano, Italy; and","institution_ids":["https://openalex.org/I4210128630"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5040992507","display_name":"Francesca Colizzi","orcid":"https://orcid.org/0000-0002-9241-511X","observed_orcids":["https://orcid.org/0000-0002-9241-511X"]},"institutions":[{"id":"https://openalex.org/I4210128630","display_name":"Centro di Riferimento Oncologico","ror":"https://ror.org/03ks1vk59","country_code":"IT","type":"healthcare","lineage":["https://openalex.org/I4210128630","https://openalex.org/I4210153126"]}],"countries":["IT"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Francesca Colizzi","raw_affiliation_strings":["2Cancer Bioimmunotherapy Unit, Department of Medical Oncology, Centro di Riferimento Oncologico, Istituto di Ricovero e Cura a Carattere Scientifico, Aviano, Italy; and"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"2Cancer Bioimmunotherapy Unit, Department of Medical Oncology, Centro di Riferimento Oncologico, Istituto di Ricovero e Cura a Carattere Scientifico, Aviano, Italy; and","institution_ids":["https://openalex.org/I4210128630"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5074959680","display_name":"Maresa Altomonte","orcid":"https://orcid.org/0000-0001-8021-1921","observed_orcids":["https://orcid.org/0000-0001-8021-1921"]},"institutions":[{"id":"https://openalex.org/I102064193","display_name":"University of Siena","ror":"https://ror.org/01tevnk56","country_code":"IT","type":"education","lineage":["https://openalex.org/I102064193"]}],"countries":["IT"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Maresa Altomonte","raw_affiliation_strings":["1Division of Medical Oncology and Immunotherapy, Department of Oncology, University Hospital of Siena, Istituto Toscano Tumori, Siena, Italy;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Division of Medical Oncology and Immunotherapy, Department of Oncology, University Hospital of Siena, Istituto Toscano Tumori, Siena, Italy;","institution_ids":["https://openalex.org/I102064193"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5024760456","display_name":"Massimo Guidoboni","orcid":"https://orcid.org/0000-0001-7703-790X","observed_orcids":["https://orcid.org/0000-0001-7703-790X"]},"institutions":[{"id":"https://openalex.org/I102064193","display_name":"University of Siena","ror":"https://ror.org/01tevnk56","country_code":"IT","type":"education","lineage":["https://openalex.org/I102064193"]}],"countries":["IT"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Massimo Guidoboni","raw_affiliation_strings":["1Division of Medical Oncology and Immunotherapy, Department of Oncology, University Hospital of Siena, Istituto Toscano Tumori, Siena, Italy;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Division of Medical Oncology and Immunotherapy, Department of Oncology, University Hospital of Siena, Istituto Toscano Tumori, Siena, Italy;","institution_ids":["https://openalex.org/I102064193"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5059941996","display_name":"Francesco Maria Marincola","orcid":"https://orcid.org/0000-0001-6423-391X","observed_orcids":["https://orcid.org/0000-0001-6423-391X"]},"institutions":[{"id":"https://openalex.org/I1299303238","display_name":"National Institutes of Health","ror":"https://ror.org/01cwqze88","country_code":"US","type":"government","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238"]},{"id":"https://openalex.org/I4210155647","display_name":"National Institutes of Health Clinical Center","ror":"https://ror.org/04vfsmv21","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238","https://openalex.org/I4210155647"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Francesco M. Marincola","raw_affiliation_strings":["3Immunogenetics Section, Department of Transfusion Medicine, Clinical Center, NIH, Bethesda, Maryland"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"3Immunogenetics Section, Department of Transfusion Medicine, Clinical Center, NIH, Bethesda, Maryland","institution_ids":["https://openalex.org/I1299303238","https://openalex.org/I4210155647"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5018536695","display_name":"Michele Maio","orcid":"https://orcid.org/0000-0002-0323-6321","observed_orcids":["https://orcid.org/0000-0002-0323-6321"]},"institutions":[{"id":"https://openalex.org/I102064193","display_name":"University of Siena","ror":"https://ror.org/01tevnk56","country_code":"IT","type":"education","lineage":["https://openalex.org/I102064193"]},{"id":"https://openalex.org/I4210128630","display_name":"Centro di Riferimento Oncologico","ror":"https://ror.org/03ks1vk59","country_code":"IT","type":"healthcare","lineage":["https://openalex.org/I4210128630","https://openalex.org/I4210153126"]}],"countries":["IT"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Michele Maio","raw_affiliation_strings":["1Division of Medical Oncology and Immunotherapy, Department of Oncology, University Hospital of Siena, Istituto Toscano Tumori, Siena, Italy;","2Cancer Bioimmunotherapy Unit, Department of Medical Oncology, Centro di Riferimento Oncologico, Istituto di Ricovero e Cura a Carattere Scientifico, Aviano, Italy; and","1Division of Medical Oncology and Immunotherapy, Department of Oncology, University Hospital of Siena, Istituto Toscano Tumori, Siena, Italy;; 2Cancer Bioimmunotherapy Unit, Department of Medical Oncology, Centro di Riferimento Oncologico, Istituto di Ricovero e Cura a Carattere Scientifico, Aviano, Italy; and"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Division of Medical Oncology and Immunotherapy, Department of Oncology, University Hospital of Siena, Istituto Toscano Tumori, Siena, Italy;","institution_ids":["https://openalex.org/I102064193"]},{"raw_affiliation_string":"2Cancer Bioimmunotherapy Unit, Department of Medical Oncology, Centro di Riferimento Oncologico, Istituto di Ricovero e Cura a Carattere Scientifico, Aviano, Italy; and","institution_ids":["https://openalex.org/I4210128630"]},{"raw_affiliation_string":"1Division of Medical Oncology and Immunotherapy, Department of Oncology, University Hospital of Siena, Istituto Toscano Tumori, Siena, Italy;; 2Cancer Bioimmunotherapy Unit, Department of Medical Oncology, Centro di Riferimento Oncologico, Istituto di Ricovero e Cura a Carattere Scientifico, Aviano, Italy; and","institution_ids":["https://openalex.org/I102064193","https://openalex.org/I4210128630"]}]}],"institutions":[],"countries_distinct_count":2,"institutions_distinct_count":4,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":1.7395,"has_fulltext":false,"cited_by_count":139,"citation_normalized_percentile":{"value":0.83966343,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":86,"max":99},"biblio":{"volume":"13","issue":"11","first_page":"3333","last_page":"3338"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10580","display_name":"Immunotherapy and Immune Responses","score":0.6904000043869019,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10580","display_name":"Immunotherapy and Immune Responses","score":0.6904000043869019,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10158","display_name":"Cancer Immunotherapy and Biomarkers","score":0.24490000307559967,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10392","display_name":"Cutaneous Melanoma Detection and Management","score":0.02280000038444996,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/decitabine","display_name":"decitabine","score":0.9940000176429749},{"id":"https://openalex.org/keywords/hypomethylating-agents","display_name":"hypomethylating agents","score":0.8209999799728394},{"id":"https://openalex.org/keywords/cutaneous-melanoma","display_name":"cutaneous melanoma","score":0.9760000109672546},{"id":"https://openalex.org/keywords/gp100","display_name":"gp100","score":0.9589999914169312},{"id":"https://openalex.org/keywords/melanocyte-differentiation-antigens","display_name":"melanocyte differentiation antigens","score":0.8450000286102295},{"id":"https://openalex.org/keywords/icam-1","display_name":"ICAM-1","score":0.9039999842643738},{"id":"https://openalex.org/keywords/lfa-3","display_name":"LFA-3","score":0.8579999804496765},{"id":"https://openalex.org/keywords/adoptive-immunotherapy","display_name":"adoptive immunotherapy","score":0.7580000162124634},{"id":"https://openalex.org/keywords/interferon-gamma","display_name":"interferon-gamma","score":0.6819999814033508}],"concepts":[{"id":"https://openalex.org/C147483822","wikidata":"https://www.wikidata.org/wiki/Q103537","display_name":"Antigen","level":2,"score":0.7224488258361816},{"id":"https://openalex.org/C147969180","wikidata":"https://www.wikidata.org/wiki/Q5014579","display_name":"CTL*","level":4,"score":0.6815812587738037},{"id":"https://openalex.org/C2777658100","wikidata":"https://www.wikidata.org/wiki/Q180614","display_name":"Melanoma","level":2,"score":0.548541247844696},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.5300806760787964},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.521485447883606},{"id":"https://openalex.org/C188280979","wikidata":"https://www.wikidata.org/wiki/Q911125","display_name":"Human leukocyte antigen","level":3,"score":0.43516603112220764},{"id":"https://openalex.org/C101180180","wikidata":"https://www.wikidata.org/wiki/Q967432","display_name":"IIf","level":4,"score":0.4331633746623993},{"id":"https://openalex.org/C153911025","wikidata":"https://www.wikidata.org/wiki/Q7202","display_name":"Molecular biology","level":1,"score":0.43156737089157104},{"id":"https://openalex.org/C2779053233","wikidata":"https://www.wikidata.org/wiki/Q731235","display_name":"ELISPOT","level":4,"score":0.41944822669029236},{"id":"https://openalex.org/C154317977","wikidata":"https://www.wikidata.org/wiki/Q376266","display_name":"Cytotoxic T cell","level":3,"score":0.41148820519447327},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.3931540548801422},{"id":"https://openalex.org/C202751555","wikidata":"https://www.wikidata.org/wiki/Q221681","display_name":"In vitro","level":2,"score":0.16533580422401428},{"id":"https://openalex.org/C167672396","wikidata":"https://www.wikidata.org/wiki/Q417800","display_name":"CD8","level":3,"score":0.10242262482643127},{"id":"https://openalex.org/C2984894117","wikidata":"https://www.wikidata.org/wiki/Q592324","display_name":"Indirect immunofluorescence","level":3,"score":0.0},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.0}],"mesh":[{"descriptor_ui":"D000077209","descriptor_name":"Decitabine","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D001374","descriptor_name":"Azacitidine","qualifier_ui":"Q000031","qualifier_name":"analogs & derivatives","is_major_topic":true},{"descriptor_ui":"D001374","descriptor_name":"Azacitidine","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007167","descriptor_name":"Immunotherapy","qualifier_ui":"Q000379","qualifier_name":"methods","is_major_topic":true},{"descriptor_ui":"D007371","descriptor_name":"Interferon-gamma","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D008545","descriptor_name":"Melanoma","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D008545","descriptor_name":"Melanoma","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":true},{"descriptor_ui":"D008562","descriptor_name":"Membrane Glycoproteins","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D012878","descriptor_name":"Skin Neoplasms","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D012878","descriptor_name":"Skin Neoplasms","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":true},{"descriptor_ui":"D013602","descriptor_name":"T-Lymphocytes, Cytotoxic","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":true},{"descriptor_ui":"D013602","descriptor_name":"T-Lymphocytes, Cytotoxic","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D015395","descriptor_name":"Histocompatibility Antigens Class I","qualifier_ui":"Q000096","qualifier_name":"biosynthesis","is_major_topic":true},{"descriptor_ui":"D015854","descriptor_name":"Up-Regulation","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D015972","descriptor_name":"Gene Expression Regulation, Neoplastic","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D019084","descriptor_name":"Fluorescent Antibody Technique, Indirect","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D020133","descriptor_name":"Reverse Transcriptase Polymerase Chain Reaction","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D045744","descriptor_name":"Cell Line, Tumor","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D058951","descriptor_name":"gp100 Melanoma Antigen","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":4,"locations":[{"id":"doi:10.1158/1078-0432.ccr-06-3091","doi":"https://doi.org/10.1158/1078-0432.ccr-06-3091","is_oa":false,"landing_page_url":"https://doi.org/10.1158/1078-0432.ccr-06-3091","pdf_url":null,"source":{"id":"https://openalex.org/S183149254","display_name":"Clinical Cancer Research","issn_l":"1078-0432","issn":["1078-0432","1557-3265"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Clinical Cancer Research","raw_type":"journal-article"},{"id":"pmid:17545540","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/17545540","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Clinical cancer research : an official journal of the American Association for Cancer Research","raw_type":"Journal Article"},{"id":"pmh:oai:sfera.unife.it:11392/2492569","doi":null,"is_oa":true,"landing_page_url":"https://aacrjournals.org/clincancerres/article/13/11/3333/193340/Functional-Up-regulation-of-Human-Leukocyte","pdf_url":null,"source":{"id":"https://openalex.org/S4306400369","display_name":"Institutional Research Information System University of Ferrara (University of Ferrara)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I201324441","host_organization_name":"University of Ferrara","host_organization_lineage":["https://openalex.org/I201324441"],"host_organization_lineage_names":[],"type":"repository"},"license":"other-oa","license_id":"https://openalex.org/licenses/other-oa","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"","raw_type":"info:eu-repo/semantics/article"},{"id":"pmh:oai:usiena-air.unisi.it:11365/1081262","doi":null,"is_oa":false,"landing_page_url":"http://hdl.handle.net/11365/1081262","pdf_url":null,"source":{"id":"https://openalex.org/S4377196319","display_name":"Use Siena air (University of Siena)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I102064193","host_organization_name":"University of Siena","host_organization_lineage":["https://openalex.org/I102064193"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"","raw_type":"info:eu-repo/semantics/article"}],"best_oa_location":{"id":"pmh:oai:sfera.unife.it:11392/2492569","doi":null,"is_oa":true,"landing_page_url":"https://aacrjournals.org/clincancerres/article/13/11/3333/193340/Functional-Up-regulation-of-Human-Leukocyte","pdf_url":null,"source":{"id":"https://openalex.org/S4306400369","display_name":"Institutional Research Information System University of Ferrara (University of Ferrara)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I201324441","host_organization_name":"University of Ferrara","host_organization_lineage":["https://openalex.org/I201324441"],"host_organization_lineage_names":[],"type":"repository"},"license":"other-oa","license_id":"https://openalex.org/licenses/other-oa","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"","raw_type":"info:eu-repo/semantics/article"},"sustainable_development_goals":[{"score":1.0,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[{"id":"https://openalex.org/F4320309746","display_name":"Compagnia di San Paolo","ror":"https://ror.org/00d1b1c41"},{"id":"https://openalex.org/F4320323054","display_name":"Associazione Italiana per la Ricerca sul Cancro","ror":"https://ror.org/02g2x7380"}],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":45,"referenced_works":["https://openalex.org/W1538171598","https://openalex.org/W1571069726","https://openalex.org/W1869453768","https://openalex.org/W1965504034","https://openalex.org/W1965527358","https://openalex.org/W1969754868","https://openalex.org/W1984550821","https://openalex.org/W1986046751","https://openalex.org/W1988006218","https://openalex.org/W1995581172","https://openalex.org/W2018227907","https://openalex.org/W2018728670","https://openalex.org/W2032650604","https://openalex.org/W2041267131","https://openalex.org/W2041696131","https://openalex.org/W2045166186","https://openalex.org/W2045246330","https://openalex.org/W2046183929","https://openalex.org/W2056964537","https://openalex.org/W2072404428","https://openalex.org/W2075660588","https://openalex.org/W2082473930","https://openalex.org/W2094652659","https://openalex.org/W2095224412","https://openalex.org/W2109895173","https://openalex.org/W2115160431","https://openalex.org/W2115293121","https://openalex.org/W2119793652","https://openalex.org/W2122507780","https://openalex.org/W2130147570","https://openalex.org/W2132562995","https://openalex.org/W2133701572","https://openalex.org/W2134296598","https://openalex.org/W2142643115","https://openalex.org/W2145883140","https://openalex.org/W2149970263","https://openalex.org/W2154643458","https://openalex.org/W2156000007","https://openalex.org/W2161650475","https://openalex.org/W2164562676","https://openalex.org/W2170596459","https://openalex.org/W2316087605","https://openalex.org/W2330826514","https://openalex.org/W2395525054","https://openalex.org/W2996919121"],"related_works":["https://openalex.org/W2075660588","https://openalex.org/W2032650604","https://openalex.org/W1995581172","https://openalex.org/W2057023729","https://openalex.org/W1969754868","https://openalex.org/W1976393347","https://openalex.org/W1488807247","https://openalex.org/W2497145793"],"abstract_inverted_index":{"PURPOSE:":[0],"To":[1],"investigate":[2],"the":[3,6,14,30,55,135,167,205,214],"potential":[4],"of":[5,16,27,33,57,59,89,119,137,151,157,169,185,194,207,216,234,237,252],"DNA":[7],"hypomethylating":[8],"agent":[9],"5-aza-2'-deoxycytidine":[10],"(5-aza-CdR)":[11],"to":[12,142,197,225],"improve":[13],"effectiveness":[15],"immunotherapeutic":[17,247],"approaches":[18,248],"against":[19,249],"melanocyte":[20],"differentiation":[21],"antigens.":[22,254],"EXPERIMENTAL":[23],"DESIGN:":[24],"The":[25,87,116],"effect":[26],"5-aza-CdR":[28,125,143,183,203,238],"on":[29,82,126],"constitutive":[31,117],"expression":[32,58,118,150],"gp100":[34,120],"was":[35,104,121],"investigated":[36,78,105],"in":[37,54,241],"11":[38],"human":[39,60],"melanoma":[40,83,93,128,140,173,208],"cell":[41],"lines":[42],"by":[43,79,100,106,124,175,210],"real-time":[44],"reverse":[45],"transcription-PCR":[46],"and":[47,67,74,111,156,178],"indirect":[48],"immunofluorescence":[49],"(IIF)":[50],"analyses.":[51],"5-aza-CdR-mediated":[52],"changes":[53,161],"levels":[56],"leukocyte":[61],"antigen":[62],"(HLA)":[63],"class":[64,153,218],"I":[65,154,219],"antigens":[66,155,220],"HLA-A2":[68],"allospecificity,":[69],"intercellular":[70],"adhesion":[71],"molecule-1":[72],"(ICAM-1),":[73],"leukocyte-function-associated":[75],"antigen-3":[76],"were":[77],"IIF":[80],"analysis":[81],"cells":[84,129,141,174,188,209],"under":[85],"study.":[86],"recognition":[88,206],"gp100-positive":[90],"Mel":[91,138,171,186],"275":[92,139,172,187],"cells,":[94,134],"treated":[95],"or":[96,245],"not":[97,122],"with":[98,132,202,243],"5-aza-CdR,":[99],"HLA-A2-restricted":[101],"gp100((209-217))-specific":[102],"CTL":[103,177,196,212],"(51)Cr-release":[107],"assays,":[108],"IFN-gamma":[109,112,181],"release":[110],"ELISPOT":[113],"assays.":[114],"RESULTS:":[115],"affected":[123],"all":[127],"investigated.":[130],"Compared":[131],"untreated":[133],"exposure":[136],"significantly":[144,162],"(P":[145,163],"<":[146,164],"0.05)":[147,165],"up-regulated":[148],"their":[149,180],"HLA":[152,217],"ICAM-1.":[158],"These":[159,228],"phenotypic":[160],"increased":[166,179],"lysis":[168],"5-aza-CdR-treated":[170],"gp100-specific":[176,195,211],"release.":[182],"treatment":[184],"also":[189,223],"induced":[190],"a":[191,231,250],"higher":[192],"number":[193],"secrete":[198],"IFN-gamma.":[199],"CONCLUSIONS:":[200],"Treatment":[201],"improves":[204],"through":[213],"up-regulation":[215],"expression;":[221],"ICAM-1":[222],"contributes":[224],"this":[226],"phenomenon.":[227],"findings":[229],"highlight":[230],"broader":[232],"range":[233],"therapeutic":[235],"implications":[236],"when":[239],"used":[240],"association":[242],"active":[244],"adoptive":[246],"variety":[251],"melanoma-associated":[253]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W2160994126","counts_by_year":[{"year":2026,"cited_by_count":3},{"year":2025,"cited_by_count":5},{"year":2024,"cited_by_count":1},{"year":2023,"cited_by_count":10},{"year":2022,"cited_by_count":16},{"year":2021,"cited_by_count":15},{"year":2020,"cited_by_count":5},{"year":2019,"cited_by_count":9},{"year":2018,"cited_by_count":5},{"year":2017,"cited_by_count":5},{"year":2016,"cited_by_count":8},{"year":2015,"cited_by_count":9},{"year":2014,"cited_by_count":9},{"year":2013,"cited_by_count":8},{"year":2012,"cited_by_count":8}],"updated_date":"2026-11-20T13:11:24.684918","created_date":"2016-06-24T00:00:00"}
